Nicholas Hoffman & Company, LLC.
Source: SEC Form 13F · as of Mar 2026Nicholas Hoffman & Company, LLC. holds 22 biotech & pharma companies tracked by BioSniper, totaling $43.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$43.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 9,761 | $9.0M |
| JNJJOHNSON & JOHNSON | 34,557 | $8.4M |
| PMPhilip Morris International Inc | 17,665 | $2.9M |
| AZNASTRAZENECA PLC | 11,880 | $2.3M |
| BMYBRISTOL MYERS SQUIBB CO | 36,658 | $2.2M |
| ABBVAbbVie Inc. | 10,203 | $2.2M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 37,910 | $2.1M |
| MRKMerck & Co., Inc. | 14,754 | $1.8M |
| NVSNovartis AG | 9,716 | $1.5M |
| ABTABBOTT LABORATORIES | 13,856 | $1.4M |
| ZBHZimmer Biomet Holdings Inc. | 15,434 | $1.4M |
| PFEPFIZER INC | 48,634 | $1.4M |
| MCKMcKesson Corporation | 1,499 | $1.3M |
| SNYSanofi | 23,788 | $1.1M |
| BAXBaxter International Inc. | 60,475 | $1.0M |
| ICLRICON plc | 8,954 | $991K |
| CORCencora Inc. | 2,649 | $832K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,579 | $698K |
| AMGNAMGEN INC | 1,093 | $384K |
| CAHCardinal Health Inc. | 1,585 | $335K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 732 | $327K |
| GILDGILEAD SCIENCES, INC. | 1,819 | $254K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.